• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kageyama Shinichi  影山 愼一

ORCIDConnect your ORCID iD *help
… Alternative Names

KAGEYAMA Shinichi  影山 愼一

影山 愼一  カゲヤマ シンイチ

影山 慎一  カゲヤマ シンイチ

Less
Researcher Number 80194695
Other IDs
Affiliation (Current) 2025: 三重大学, 医学系研究科, リサーチアソシエイト
Affiliation (based on the past Project Information) *help 2020 – 2023: 三重大学, 医学系研究科, リサーチアソシエイト
2019: 三重大学, 医学系研究科, 教授
2016 – 2017: 三重大学, 医学系研究科, 教授
2014 – 2015: 三重大学, 医学(系)研究科(研究院), 教授
2012 – 2013: 三重大学, 医学(系)研究科(研究院), 准教授 … More
2009 – 2011: Mie University, 大学院・医学系研究科, 准教授
2005: 三重大学, 大学院・医学系研究科, 助教授
2001 – 2004: 三重大学, 医学部, 助手
2000: 三重大学, 医学部・附属病院, 助手 Less
Review Section/Research Field
Principal Investigator
Digestive surgery / Basic Section 55020:Digestive surgery-related / Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields / Otorhinolaryngology
Except Principal Investigator
Biological Sciences
Keywords
Principal Investigator
食道癌 / がんワクチン / CAR-T療法 / がん免疫療法 / 免疫モニタリング / バイオマーカー / MAGE-A4 / CAR-T細胞 / TCR遺伝子導入T細胞 / 遺伝子改変T細胞輸注療法 … More / T細胞治療 / TCR遺伝子導入細胞療法 / 複合的がん免疫療法 / 臨床試験 … More
Except Principal Investigator
制御性T細胞 / ヘルパーT細胞 / キラーT細胞 / HLA-A24 / 癌精巣抗原 / 抗原ペプチド / 遺伝子治療 / レトロウイルスベクター / T細胞療法 / TCR / 精巣抗原 / 癌 / アジュバント / ペプチドワクチン / TCR遺伝子改変T細胞 / GITR / ペプチド抗原 / マルチファンクション性T細胞 / 癌・精巣抗原 / DNAワクチン / CTL / 原癌遺伝子 / ヘルパーエピトープ / CTLエピトープ / SEREX / ペプチド / SEREX抗原 / 抗原デリバリーシステム / 蛋白抗原 / 疎水化多糖類 / HER2 / 癌ワクチン / 癌遺伝子 Less
  • Research Projects

    (7 results)
  • Research Products

    (60 results)
  • Co-Researchers

    (13 People)
  •  Biomarker-based manufacture of MAGE-A4/CAR-T cell in immunotherapy for esophageal cancerPrincipal Investigator

    • Principal Investigator
      Kageyama Shinichi
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 55020:Digestive surgery-related
    • Research Institution
      Mie University
  •  T cell optimization for effective CAR-T cell therapy to refractory esophageal cancerPrincipal Investigator

    • Principal Investigator
      Kageyama Shinichi
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields
    • Research Institution
      Mie University
  •  Optimization of cancer vaccine that are combined with TCR-gene transduced T cell transfer for esophageal cancerPrincipal Investigator

    • Principal Investigator
      Kageyama Shinichi
    • Project Period (FY)
      2015 – 2017
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Digestive surgery
    • Research Institution
      Mie University
  •  Spreading immune-reactions in esophageal cancer patients who were given cancer vaccine and whose tumors co-express additional antigensPrincipal Investigator

    • Principal Investigator
      KAGEYAMA Shinichi
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Digestive surgery
    • Research Institution
      Mie University
  •  Immunomonitoring in head and neck cancer patients treated with protein vaccine through tumor destructionPrincipal Investigator

    • Principal Investigator
      KAGEYAMA Shinichi
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Otorhinolaryngology
    • Research Institution
      Mie University
  •  Polyvalent cancer vaccine

    • Principal Investigator
      SHIKU Hiroshi
    • Project Period (FY)
      2005 – 2009
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Review Section
      Biological Sciences
    • Research Institution
      Mie University
  •  がん遺伝子産物由来ペプチド抗原によるがん治療

    • Principal Investigator
      SHIKU Hiroshi
    • Project Period (FY)
      2000 – 2004
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Review Section
      Biological Sciences
    • Research Institution
      Mie University

All 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Other

All Journal Article Presentation Book

  • [Book] Immunotyerapy of Cancer(分担)2016

    • Author(s)
      Shinichi Kageyama
    • Total Pages
      358
    • Publisher
      Springer
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Book] がん免疫療法-実用化へのチャレンジ-2010

    • Author(s)
      影山愼一
    • Publisher
      シーエムシー出版
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Book] がん免疫療法-実用化へのチャレンジ2010

    • Author(s)
      影山愼一
    • Total Pages
      250
    • Publisher
      シーエムシー出版
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Journal Article] A phase 1 trial of <scp>NY‐ESO</scp> ‐1‐specific <scp>TCR</scp> ‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma2023

    • Author(s)
      Ishihara Mikiya、Nishida Yoshihiro、Kitano Shigehisa、Kawai Akira、Takada Kohichi、Emori Makoto、Kageyama Shinichi、Shiku Hiroshi
    • Journal Title

      International Journal of Cancer

      Volume: 152 Issue: 12 Pages: 2554-2566

    • DOI

      10.1002/ijc.34453

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K08080, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-20K16411, KAKENHI-PROJECT-21K19561, KAKENHI-PROJECT-21K06690, KAKENHI-PROJECT-23K08700, KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K07277, KAKENHI-PROJECT-23K24180
  • [Journal Article] NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome2022

    • Author(s)
      Ishihara M, Kitano S, Kageyama S, Miyahara Y, Yamamoto N, Kato H, Mishima H, Hattori H, Funakoshi T, Kojima T, Sasada T, Sato E, Okamoto S, Tomura D, Nukaya I, Chono H, Mineno J, Kairi MF, Diem Hoang Nguyen P, Simoni Y, Nardin A, Newell E, Fehlings M, Ikeda H, Watanabe T, Shiku H.
    • Journal Title

      J Immunother Cancer

      Volume: 10 Issue: 6 Pages: e003811-e003811

    • DOI

      10.1136/jitc-2021-003811

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K08876, KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-21H02990, KAKENHI-PROJECT-21H02995, KAKENHI-PROJECT-23K24180
  • [Journal Article] Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial2022

    • Author(s)
      Satoshi Okumura, Mikiya Ishihara, Naomi Kiyota, Kimikazu Yakushijin, Kohichi Takada, Shinichiro Kobayashi, Hiroaki Ikeda, Makoto Endo, Koji Kato, Shigehisa Kitano, Akihiko Matsumine, Yasuhiro Nagata,...Hiroshi Shiku
    • Journal Title

      BMJ Open

      Volume: 12(11) Issue: 11 Pages: e065109-e065109

    • DOI

      10.1136/bmjopen-2022-065109

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K06690, KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K08080, KAKENHI-PROJECT-22K08876, KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-21K16400, KAKENHI-PROJECT-21H02990, KAKENHI-PROJECT-20K09731, KAKENHI-PROJECT-23K24456, KAKENHI-PROJECT-23K24180
  • [Journal Article] Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.2022

    • Author(s)
      Yasuhiro Nagata, Shinichi Kageyama, Takeshi Ishikawa, Satoshi Kokura, Tetsuya Okayama, Tetsuya Abe,...Hiroshi Shiku
    • Journal Title

      Cancer immunology, immunotherapy : CII

      Volume: CII 71(11) Issue: 11 Pages: 2743-2755

    • DOI

      10.1007/s00262-022-03194-5

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K06690, KAKENHI-PROJECT-21K08682, KAKENHI-PROJECT-22K19532, KAKENHI-PROJECT-22K19694, KAKENHI-PROJECT-21K16400, KAKENHI-PROJECT-21H04833, KAKENHI-PROJECT-21H02990, KAKENHI-PROJECT-23K24180
  • [Journal Article] Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients2021

    • Author(s)
      Ishikawa T, Kageyama S, Miyahara Y, Okayama T, Kokura S, Wang L, Sato E, Yagita H, Itoh Y, Shiku H.
    • Journal Title

      Cancer Immunol Immunother

      Volume: Online ahead of print Issue: 11 Pages: 3081-3091

    • DOI

      10.1007/s00262-021-02892-w

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-19K22655
  • [Journal Article] First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.2020

    • Author(s)
      Ishihara M, Tono Y, Miyahara Y, Muraoka D, Harada N, Kageyama S, Sasaki T, Hori Y, Soga N, Uchida K, Shiraishi T, Sato E, Kanda H, Mizuno T, Webster GA, Ikeda H, Katayama N, Sugimura Y, Shiku H.
    • Journal Title

      Cancer Immunol Immunother

      Volume: 69 Issue: 4 Pages: 663-675

    • DOI

      10.1007/s00262-020-02483-1

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-19K09048, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-19K21599, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-17K09923, KAKENHI-PROJECT-19K22655, KAKENHI-PROJECT-19H03729
  • [Journal Article] MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours2020

    • Author(s)
      Ishihara Mikiya、Kageyama Shinichi、Miyahara Yoshihiro、Ishikawa Takeshi、Ueda Shugo、Soga Norihito、Naota Hiroaki、Mukai Katsumi、Harada Naozumi、Ikeda Hiroaki、Shiku Hiroshi
    • Journal Title

      BMC Cancer

      Volume: 20 Issue: 1 Pages: 606-606

    • DOI

      10.1186/s12885-020-07098-4

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K21599, KAKENHI-PROJECT-19K22655, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-18K19584
  • [Journal Article] Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma.2019

    • Author(s)
      Kakimoto T, Matsumine A, Kageyama S, Asanuma K, Matsubara T, Nakamura T, Iino T, Ikeda H, Shiku H, Sudo A
    • Journal Title

      Oncology Letters

      Volume: 17 Pages: 3937-3943

    • DOI

      10.3892/ol.2019.10044

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872, KAKENHI-PROJECT-19K22655, KAKENHI-PROJECT-16K10856
  • [Journal Article] Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination2018

    • Author(s)
      Abiko Takehiro、Tsuchikawa Takahiro、Miyauchi Kengo、Wada Masataka、Kyogoku Noriaki、Shichinohe Toshiaki、Miyahara Yoshihiro、Kageyama Shinichi、Ikeda Hiroaki、Shiku Hiroshi、Hirano Satoshi
    • Journal Title

      Oncology Letters

      Volume: 15 Pages: 3703-3711

    • DOI

      10.3892/ol.2018.7767

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-18K19584, KAKENHI-PROJECT-18H02872
  • [Journal Article] Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination2018

    • Author(s)
      Wada M, Tsuchikawa T, Kyogoku N, Abiko T, Miyauchi K, Takeuchi S, Kuwatani T, Shichinohe T, Miyahara Y, Kageyama S, Ikeda H, Shiku H, Hirano S
    • Journal Title

      Anticancer Res

      Volume: 38 Pages: 1435-1444

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Journal Article] Cancer immunotherapy using gene-engineered T cells2018

    • Author(s)
      影山 愼一
    • Journal Title

      Rinsho Ketsueki

      Volume: 59 Issue: 2 Pages: 216-224

    • DOI

      10.11406/rinketsu.59.216

    • NAID

      130006441932

    • ISSN
      0485-1439, 1882-0824
    • Language
      Japanese
    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Journal Article] Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.2017

    • Author(s)
      Tawara I, Kageyama S, Miyahara Y, Fujiwara H, Nishida T, Akatsuka Y, Ikeda H, Tanimoto K, Terakura S, Murata M, Inaguma Y, Masuya M, Inoue N, Kidokoro T, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Naoe T, Emi N, Yasukawa M, Katayama N, Shiku H.
    • Journal Title

      Blood

      Volume: 130 Issue: 18 Pages: 1985-1994

    • DOI

      10.1182/blood-2017-06-791202

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K09307, KAKENHI-PROJECT-17K09923, KAKENHI-PROJECT-17K09949, KAKENHI-PROJECT-17K09957, KAKENHI-PROJECT-15H04858, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-15K09497, KAKENHI-PROJECT-15K09498, KAKENHI-PROJECT-15K09506, KAKENHI-PROJECT-15K10093
  • [Journal Article] Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy2017

    • Author(s)
      Yokoyama S, Tamaru S, Tamaki S, Nakanishi D, Mori A, Yamakawa T, Ao T, Sakata Y, Mizuno T, Iwamoto T, Watanabe K, Simomura M, Kawakami K, Konishi N, Kageyama S, Ohtani S, Yamada T, Ban S, Ooi K
    • Journal Title

      Clin Breast Cancer

      Volume: S1526-8209 Issue: 2 Pages: 507-511

    • DOI

      10.1016/j.clbc.2017.05.013

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Journal Article] Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting.2017

    • Author(s)
      Tanaka Y, Ohishi K, Sawai T, Iwasaki H, Kageyama S, Masuya M, Matsumoto T, Tanigawa T, Wada H, Shiku H, Ito M, Katayama N
    • Journal Title

      Ther Apher Dial.

      Volume: 21 Issue: 5 Pages: 507-511

    • DOI

      10.1111/1744-9987.12562

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K08645, KAKENHI-PROJECT-16K09307, KAKENHI-PROJECT-17K09923, KAKENHI-PROJECT-15K10093
  • [Journal Article] Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel.2016

    • Author(s)
      Kyogoku N, Ikeda H, Tsuchikawa T, Abiko T, Fujiwara A, Maki T, Yamamura Y, Ichinokawa M, Tanaka K, Imai N, Miyahara Y, Kageyama S, Shiku H, Hirano S.
    • Journal Title

      Oncology Letters

      Volume: 12 Issue: 6 Pages: 4493-4504

    • DOI

      10.3892/ol.2016.5253

    • NAID

      120005981404

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-26461935, KAKENHI-PROJECT-15K10093
  • [Journal Article] Clinical relevance of antigen spreading pattern induced by CHP-MAGE-A4 cancer vaccination2016

    • Author(s)
      Miyauchi K, Tsuchikawa T, Wada M, Abiko T, Kyogoku N, Shichinohe T, Miyahara Y, Kageyama S, Ikeda H, Shiku H, Hirano S.
    • Journal Title

      Immunotherapy

      Volume: 印刷中 Issue: 5 Pages: 527-40

    • DOI

      10.2217/imt-2016-0007

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-26461935
  • [Journal Article] Adoptive transfer of MAGE-A4 T-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal cancer2015

    • Author(s)
      Kageyama S, Ikeda H, Miyahara Y, Imai N, Ishihara M, Saito K, Sugino S, Ueda S, Ishikawa T, Kokura S, Naota H, Ohishi K, Shiraishi T, Inoue N, Tanabe M, Kidokoro T, Yoshioka H, Tomura D, Nukaya I, Mineno J, Takesako K, Katayama N, Shiku H.
    • Journal Title

      Clinical Cancer Research

      Volume: in press Issue: 10 Pages: 2268-2277

    • DOI

      10.1158/1078-0432.ccr-14-1559

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-25350612, KAKENHI-PROJECT-25461413, KAKENHI-PROJECT-15K10093, KAKENHI-PROJECT-15H04918, KAKENHI-PROJECT-25461447
  • [Journal Article] High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine2014

    • Author(s)
      Saito T, Wada H, Yamasaki M, Miyata H, Nishikawa H, Sato E, Kageyama S, Shiku H, Mori M, Doki Y.
    • Journal Title

      Vaccine

      Volume: 32 Issue: 45 Pages: 5901-5907

    • DOI

      10.1016/j.vaccine.2014.09.002

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-26290054, KAKENHI-PROJECT-26670581
  • [Journal Article] Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients2013

    • Author(s)
      Kageyama S, Wada H, Muro K, Niwa Y, Ueda S, Miyata H, Takiguchi S, Sugino SH, Miyahara Y, Ikeda H, Imai N, Sato E, Yamada T, Osako M, Ohnishi M, Harada N, Hishida T, Doki Y, Shiku H
    • Journal Title

      Journal of translational medicine

      Volume: 5;11 Issue: 1 Pages: 246-246

    • DOI

      10.1186/1479-5876-11-246

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23501284, KAKENHI-PROJECT-24390300, KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-24591965, KAKENHI-PROJECT-24650259
  • [Journal Article] Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes2013

    • Author(s)
      Hirayama M, Nishikawa H, Nagata Y, Tsuji T, Kato T, Kageyama S, Ueda S, Sugiyama D, Hori S, Sakaguchi S, Ritter G, Old LJ, Gnjatic S, and Shiku H
    • Journal Title

      Eur J Immunol

      Volume: 43 (4) Issue: 4 Pages: 989-1000

    • DOI

      10.1002/eji.201242800

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23300354, KAKENHI-PROJECT-24591939, KAKENHI-PROJECT-24591965, KAKENHI-PROJECT-25670553
  • [Journal Article] CHPがん蛋白ワクチン2011

    • Author(s)
      影山愼一
    • Journal Title

      腫瘍内科

      Volume: 8巻 Pages: 446-451

    • Data Source
      KAKENHI-PROJECT-21592191
  • [Journal Article] 治療用がんワクチン開発のためのFDAからのガイダンス2011

    • Author(s)
      影山愼一
    • Journal Title

      腫瘍内科

      Volume: 8巻 Pages: 167-171

    • NAID

      40018983468

    • Data Source
      KAKENHI-PROJECT-21592191
  • [Journal Article] 抗腫瘍ワクチン2010

    • Author(s)
      影山愼一
    • Journal Title

      日本臨床

      Volume: 68 Pages: 1100-1104

    • Data Source
      KAKENHI-PROJECT-21592191
  • [Journal Article] Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia2010

    • Author(s)
      Ohtake S, Miyawaki S, Kiyoi H, Miyazaki Y, Okumura H, Matsuda S, Nagai T, Kishimoto Y, Okada M, Takahashi M, Handa H, Takeuchi J, Kageyama S, Asou N, Yagasaki F, Maeda Y, Ohnishi K, Naoe T
    • Journal Title

      JALSG AML95 study Int J Hematol

      Volume: 91 Pages: 276-283

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Journal Article] Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study2010

    • Author(s)
      Ohtake S, Miyawaki S, Kiyoi H, Miyazaki Y, Okumura H, Matsuda S, Nagai T, Kishimoto Y, Okada M, Takahashi M, Handa H, Takeuchi J, Kageyama S, Asou N, Yagasaki F, Maeda Y, Ohnishi K, Naoe T, Ohno R
    • Journal Title

      Int J Hematol (印刷中)

    • NAID

      10026111520

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009

    • Author(s)
      Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
    • Journal Title

      Vaccine 47

      Pages: 6854-6861

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009

    • Author(s)
      Aoki M., Ueda S., Nishikawa H., Kitano S., Hirayama M., Ikeda H., Toyoda H., Tanaka K., Kanai M., Takabayashi A., Imai H., Shiraishi T., Sato E., Wada H., Nakayama E., Takei Y., Katayama N., Shiku H., Kageyama S
    • Journal Title

      Vaccine 27

      Pages: 6854-61

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17016031
  • [Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.2009

    • Author(s)
      Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
    • Journal Title

      Vaccine 27(49)

      Pages: 6854-6861

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17016031
  • [Journal Article] Antibody responses against NY-ESO-1 and HER2 antigens in patientsvaccinated with combinations of cholesteryl pullulan(CHP)-NY-ESO-1 and CHP-HER2 with OK-4322009

    • Author(s)
      Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S
    • Journal Title

      Vaccine

      Volume: 27 Pages: 6854-6861

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Journal Article] Humoral immune responses in patients vaccinated with 1-146 HER2 Protein complexed with cholesteryl pullulan nanogel(CHP-HER2)2008

    • Author(s)
      Kageyama S., Kitano S., Hirayama M., Nagata Y., Imai H., Shiraishi T., Akiyoshi K., Scott A., Murphy R., Hoffman E., Old L., Katayama N., Shiku H
    • Journal Title

      Cancer Science 99

      Pages: 601-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17016031
  • [Journal Article] Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel (CHP-HER2)2008

    • Author(s)
      Kageyama S, Kitano S, Hirayama M, Nagata Y, Imai H, Shiraishi T, Akiyoshi K, Scott A, Murphy R, Hoffman E, Old, L, Katayama N, Shiku H
    • Journal Title

      Cancer Science 99(3)

      Pages: 601-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17016031
  • [Journal Article] HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan2006

    • Author(s)
      Kitano S., Kageyama S., Nagata Y., Miyahara Y., Hiasa A., Naota H., Okumura S., Imai H., Shiraishi T., Masuya M., Nishikawa M., Sunamoto J., Akiyoshi K., Kanematsu T., Scott AM., Murphy R., Hoffman EW., Old LJ., Shiku H
    • Journal Title

      Clin. Cancer Res 12

      Pages: 7397-405

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17016031
  • [Presentation] TCR gene-transduced T-cell therapy for sarcoma2021

    • Author(s)
      影山愼一
    • Organizer
      第18回日本臨床腫瘍学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-19K22655
  • [Presentation] MAGE-A4及びNY-ESO-1抗原特異的 TCR遺伝子改変T細胞輸注療法の臨床試験2017

    • Author(s)
      影山 愼一
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Presentation] 治療抵抗性固形腫瘍を対象とした NY-ESO-1及びMAGE-A4を標的にするTCR遺伝子導入 T細胞輸注療法の臨床試験2017

    • Author(s)
      影山 愼一
    • Organizer
      第23回日本遺伝子細胞治療学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Presentation] Cytokine Release Syndrome and Tumor Responses in a First-in-Man Trial of a Novel Affinity-Enhanced TCR-Gene Transduced T Cell Transfer Targeting NY-ESO-1 Antigen2017

    • Author(s)
      影山 愼一
    • Organizer
      59th ASH Annual Meeting & Exposition 第59回米国血液学会総会
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Presentation] Clinical trials of adoptive transfer of TCR-modified T cell therapy for refractory cancer2017

    • Author(s)
      影山 愼一
    • Organizer
      8th Annual Meeting of Asian Cellular Therapy Organization 第8回アジア細胞療法学会
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Presentation] 食道癌に対するがんワクチンとT細胞療法の臨床試験2017

    • Author(s)
      影山 愼一
    • Organizer
      第15回日本臨床腫瘍学会学術集会
    • Invited
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Presentation] 食道癌に対する免疫療法:がんワクチンと免疫細胞治療2016

    • Author(s)
      影山愼一
    • Organizer
      第70回日本食道学会学術集会
    • Place of Presentation
      ザ・プリンス パークタワー東京(東京都・港区)
    • Invited
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Presentation] 滑膜肉腫に対するTCR改変T細胞を用いた 免疫細胞輸注療法2015

    • Author(s)
      影山愼一 松峯昭彦
    • Organizer
      第53回日本癌治療学会学術総会
    • Place of Presentation
      国立京都国際会館(京都府・京都市)
    • Year and Date
      2015-10-31
    • Invited
    • Data Source
      KAKENHI-PROJECT-15K10093
  • [Presentation] 食道癌に対する免疫療法―がんワクチンと免疫細胞療法―2014

    • Author(s)
      影山愼一
    • Organizer
      第12回日本臨床腫瘍学会学術集会
    • Place of Presentation
      福岡国際会議場(福岡市)
    • Year and Date
      2014-07-19
    • Invited
    • Data Source
      KAKENHI-PROJECT-24591939
  • [Presentation] TCR-gene engineered T cell transfer as a treatment for refractory esophageal cancer2014

    • Author(s)
      影山愼一
    • Organizer
      第12回日本臨床腫瘍学会学術集会
    • Place of Presentation
      福岡国際会議場(福岡市)
    • Year and Date
      2014-07-18
    • Invited
    • Data Source
      KAKENHI-PROJECT-24591939
  • [Presentation] Immune responses and survival benefits of esophageal cancer patients vaccinated with NY-ESO-1(CHP-NY-ESO-1); P1 trial2013

    • Author(s)
      影山愼一
    • Organizer
      第11回日本臨床腫瘍学会総会
    • Place of Presentation
      仙台市
    • Data Source
      KAKENHI-PROJECT-24591939
  • [Presentation] 大学発トランスレーショナルリサーチの経験から2012

    • Author(s)
      影山愼一、珠玖 洋
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌市
    • Data Source
      KAKENHI-PROJECT-24591939
  • [Presentation] 疎水化多糖・タンパクがんワクチンTRからのレッスン2011

    • Author(s)
      影山愼一
    • Organizer
      第49回日本癌治療学会学術総会
    • Place of Presentation
      名古屋市
    • Year and Date
      2011-10-28
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] 疎水化多糖・タンパクがんワクチンTRからのレッスン2011

    • Author(s)
      影山愼一
    • Organizer
      第49回日本癌治療学会学術総会
    • Place of Presentation
      名古屋国際会議場
    • Year and Date
      2011-10-28
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] CHP-抗原蛋白のがんワクチン橋渡し研究2011

    • Author(s)
      影山愼一
    • Organizer
      第14回日本がん免疫学会総会
    • Place of Presentation
      熊本市
    • Year and Date
      2011-07-22
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] MAGE-A4抗原を発現する非小細胞性肺癌細胞株におけるMAGE-A4発現の検討2010

    • Author(s)
      影山愼一, 他
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪市
    • Year and Date
      2010-09-24
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] MAGE-A4抗原を発現する難治性悪性腫瘍に対するCHP-MAGE-A4がんワクチン臨床試験(第I+II相試験)2010

    • Author(s)
      京極典憲、影山愼一
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪市
    • Year and Date
      2010-09-24
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] CHP-抗原がんワクチンのトランスレーショナルリサーチを通じた得られた成果と課題2010

    • Author(s)
      影山愼一
    • Organizer
      第13回日本がん免疫学会総会
    • Place of Presentation
      北九州市
    • Year and Date
      2010-06-24
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] MAGE-A4抗原を発現する難治性悪性腫瘍に対するCHP-MAGE-A4がんワクチン臨床試験(第I+ II相試験)2010

    • Author(s)
      影山愼一, 他
    • Organizer
      第69回日本癌学会学術総会
    • Place of Presentation
      大阪市
    • Year and Date
      2010-09-24
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] CHP-蛋白がんワクチンのトランスレーショナルリサーチを通じて得られた成果と課題2009

    • Author(s)
      影山愼一
    • Organizer
      第13回日本がん免疫学会総会
    • Place of Presentation
      北九州市
    • Year and Date
      2009-06-24
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] OK-432を用いたCHP-NY-ESO-1蛋白ワクチンにより誘導されたCD4+ T細胞の解析2009

    • Author(s)
      影山愼一, 他
    • Organizer
      第68回日本癌学会学術総会
    • Place of Presentation
      横浜市
    • Year and Date
      2009-10-01
    • Data Source
      KAKENHI-PROJECT-21592191
  • [Presentation] Combination cancer vaccine of CHP-NY-ESO-1 and CHP-HER2 with immuno-adjuvant, OK-432, for chemorefractory metastatic or recurrent esophageal cancer patients2008

    • Author(s)
      Ueda S, Aoki M, Nishikawa H, Hirayama M, Kitano S, Hayashi E, Kanai M, Takabayashi A, Shiku H, Kageyama S
    • Organizer
      American Association for Cancer Research 99th Annual Meeting
    • Place of Presentation
      San Diego, USA
    • Data Source
      KAKENHI-PROJECT-17016031
  • [Presentation] A clinical trial of CHP-HER2 vaccine with adjuvant GM-CSF:A case representing antigen spreading2007

    • Author(s)
      Kitano S, Kageyama S, Nishikawa H, Hirayama M, Hiasa A, Ikeda H, Old LJ, Shiku H
    • Organizer
      15th Cancer Research Institute Annual symposium
    • Place of Presentation
      NY, USA
    • Data Source
      KAKENHI-PROJECT-17016031
  • [Presentation] Humoral immune responses in patients vaccinated with HER2 protein complexed with a novel antigen delivery system of cholesteryl pullulan(CHP-HER2)2006

    • Author(s)
      Kitano S, Hirayama M, Kageyama S, Nagata Y, Nishikawa H, Scott AM, Murphy R, Hoffman EW, Old LJ, Shiku H
    • Organizer
      97TH Annual Meeting of American Association for Cancer Reseach
    • Place of Presentation
      Washington DC, USA
    • Data Source
      KAKENHI-PROJECT-17016031
  • [Presentation] NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) provides dose-dependent effects on immune responses and survival benefits for recurrent esophageal cancer patients.

    • Author(s)
      影山愼一
    • Organizer
      The European Cancer Congress 2013(2013年欧州がん会議)
    • Place of Presentation
      アムステルダム(オランダ)
    • Data Source
      KAKENHI-PROJECT-24591939
  • 1.  SHIKU Hiroshi (80154194)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 8 results
  • 2.  宮原 慶裕 (10582083)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 3.  YUTA Atsushi (80293778)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  渡辺 正人 (30220924)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  片山 直之 (20185812)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  加藤 琢磨 (60224515)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  MASUYA Masahiro
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 8.  IKEDA Hiroaki
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 4 results
  • 9.  NAGATA Yasuhiro
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 10.  西川 博嘉
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 11.  和田 英夫
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 12.  高田 弘一
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 13.  曽我 倫久人
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi